slides · global inventory
Present Framework
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 10,656
Current window 6,271-6,300
Pages 356
Rows per page 30
Slide function
6,271-6,300 of 10,656
07
The slide outlines a standard randomized controlled trial (RCT) design for a pharmaceutical study.Albireo Pharma | Results Presentation Deck | 18 slides · Albireo Pharma
Conference presentation Investor relations Beat · Agitate1 hit
08
The slide outlines a clinical trial protocol with two study arms (ADX-2191 vs. routine care) over a 6-month period.Aldeyra Therapeutics | Results Presentation Deck | 13 slides · Aldeyra Therapeutics
Conference presentation Investor relations 1 hit
15
Uses a Venn diagram to show the intersection of two business units.AlTi | Investor Presentation Deck | 46 slides · Alvarium Tiedemann
Pitch deck Investor relations Beat · Solution1 hit
19
The slide uses a circular process diagram to represent a flywheel or virtuous cycle.Apollo Medical Holdings | Investor Presentation Deck | 45 slides · Apollo Medical Holdings
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
06
The slide outlines a multi-stage clinical trial process including patient identification, open-label, and placebo-controlled phases.argenx SE | Results Presentation Deck | 19 slides · argenx
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
12
The central diagram is a circular flow/flywheel representation.argenx SE | Results Presentation Deck | 19 slides · argenx
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
16
The 2x2 grid is used to present the four principles.Asos | Results Presentation Deck | 27 slides · Asos
Conference presentation Investor relations 1 hit
23
Asos | Results Presentation Deck | 27 slidesAsos | Results Presentation Deck | 27 slides · Asos
Conference presentation Investor relations 1 hit
16
The slide uses a standard clinical trial flow diagram (randomization to treatment arms).ATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
17
The slide uses a comparison structure to contrast safety/tolerability goals against efficacy goals.ATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
26
The slide uses a process flow diagram to represent clinical trial cohorts and SMG (Safety Monitoring Group) review gates.ATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
29
Slide 29 of the presentation.ATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
36
Includes study design diagram and assessment schedule table.ATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
39
The slide outlines two distinct clinical study parts: a Single Ascending Dose (SAD) study and a crossover comparator study.ATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
06
The slide uses a process-flow style table to outline the clinical trial structure.Athira Pharma | Results Presentation Deck | 11 slides · Athira Pharma
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
08
The framework is a clinical trial decision matrix based on ADAS-Cog11 and ADCS-ADL23 scores.Athira Pharma | Results Presentation Deck | 11 slides · Athira Pharma
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
32
The slide uses a 2x2 matrix to map specific industry players against two strategic dimensions.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
13
The slide uses a complex overlapping circle diagram to map psychiatric conditions. Source: Stein MB & Stein DJ. Lancet 2008.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
15
The slide outlines a standard clinical decision-making process for pharmacotherapy.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
22
The slide displays a snippet of the LSAS questionnaire, showing the scoring criteria for 'Fear or Anxiety' and 'Avoidance' and providing examples of the 24 items.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Solution1 hit
29
This is a standard clinical measurement tool for anxiety and distress levels.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
30
The table maps specific time intervals (pre-dose, resting, preparation, performance, post-challenge) to data collection points.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
36
The slide uses a hierarchical list to detail the research methodology.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Traction1 hit
55
The slide uses a hierarchical decomposition framework to show how revenue is derived from epidemiological and commercial assumptions.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
05
Blue Water Vaccines | Results Presentation Deck | 15 slidesBlue Water Vaccines | Results Presentation Deck | 15 slides · Blue Water Vaccines
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
05
The slide uses a timeline-based process diagram to explain the clinical trial structure.BrainStorm Cell Therapeutics | Investor Presentation Deck | 15 slides · Brainstorm Cell Therapeutics
Conference presentation Investor relations Beat · AgitateLoop · Before After1 hit
06
Mentions specific statistical models: PCA, MMRM, and mixed stepwise regression.BrainStorm Cell Therapeutics | Investor Presentation Deck | 15 slides · Brainstorm Cell Therapeutics
Conference presentation Investor relations Beat · SolutionLoop · Before After1 hit
07
The slide outlines the primary endpoint (Clinical Response) and a secondary/supporting metric (piecewise slope) for ALS clinical trials.BrainStorm Cell Therapeutics | Investor Presentation Deck | 15 slides · Brainstorm Cell Therapeutics
Conference presentation Investor relations Beat · SolutionLoop · Before After1 hit
09
The slide uses a central hub-and-spoke style diagram to connect pillars to ambitions, with a footer emphasizing safety as a non-negotiable value.Braskem | ESG Presentation Deck | 54 slides · Braskem
Conference presentation Investor relations Beat · ComplicationLoop · Cost Of Inaction1 hit
13
The slide uses a numbered list structure to define the three work fronts.Braskem | ESG Presentation Deck | 54 slides · Braskem
Conference presentation Investor relations Beat · Problem (Identify pain)1 hit